KOBAYASHI Hirohito
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine Position Associate Professor |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. |
Journal | Formal name:Japanese journal of clinical oncology Abbreviation:Jpn J Clin Oncol ISSN code:(1465-3621)0368-2811(Linking) |
Volume, Issue, Page | 47(12),pp.1175-1181 |
Author and coauthor | Ishihara Hiroki, Kondo Tsunenori*, Fukuda Hironori, Yoshida Kazuhiko, Omae Kenji, Takagi Toshio, Iizuka Junpei, Kobayashi Hirohito, Tanabe Kazunari |
Publication date | 2017/12 |
Summary | Deterioration of renal function was stronger with SU than SO. During SU therapy, renal function should be monitored and pre-treatment kidney function should be taken into consideration for therapy selection. |
DOI | 10.1093/jjco/hyx161 |
PMID | 29140528 |